Address
Email address
Phone number
Website
Kevelt is an Estonian pharmaceutical company that is engaged in the manufacturing, resale and subcontracting of pharmaceuticals.
Name
KEVELT AS
Registry code
10418580
VAT number
EE100140077
Type
AS - Joint Stock Company
Status
Registered
Foundation date
24.03.1998 (27)
Financial year
01.01-31.12
Capital
127 800.00 €
Activity
74901 - Other professional, scientific and technical activities n.e.c. 21201 - Manufacture of pharmaceutical preparations
-
-
-
-
-
-
-
No tax arrears
-
-
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Omanikukonto: DMITRY GENKIN
| 100% - 127 800.00 EUR | - | - | Shareholder |
Aleksei Shafranov
| - | Board member | - | |
Allan Ahtloo
| - | Board member | - | |
Sergey Avtushenko
| - | - | - | Board member |
Kirill Surkov
| - | - | - | Board member |
Dmitry Genkin
| - | - | - | Chairman of the board |
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
EPhaG OÜ 11081600 | 2% - 5 367.60 EUR | - | - | |
Cayman Europe OÜ 11100176 | - | - | - | Founder |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q4 | 1 340 805.58 € | 63 863.31 € | 71 079.88 € | 35 |
2024 Q3 | 382 988.99 € | 109 001.86 € | 115 063.26 € | 36 |
2024 Q2 | 913 502.88 € | 87 603.85 € | 92 330.42 € | 34 |
2024 Q1 | 644 444.9 € | 76 778.36 € | 82 025.65 € | 36 |
2023 Q4 | 978 397.12 € | 138 334.93 € | 142 516.96 € | 33 |
2023 Q3 | 498 788.36 € | 138 808.43 € | 143 425.29 € | 32 |
2023 Q2 | 868 188.08 € | 106 260.5 € | 109 979.44 € | 30 |
2023 Q1 | 190 607.16 € | 90 786.71 € | 94 513.69 € | 29 |
2022 Q4 | 773 050.02 € | 77 829.47 € | 80 820.35 € | 29 |
2022 Q3 | 636 915.34 € | 92 204.96 € | 95 988.63 € | 28 |
2022 Q2 | 884 939.81 € | 67 166.79 € | 72 275.76 € | 31 |
2022 Q1 | 676 056.53 € | 73 833.65 € | 78 398.9 € | 34 |
2021 Q4 | 1 583 228.88 € | 112 039.38 € | 116 174.78 € | 34 |
2021 Q3 | 515 791.95 € | 114 700.17 € | 119 449.94 € | 32 |
2021 Q2 | 1 046 157.43 € | 62 453.39 € | 67 152.89 € | 34 |
2021 Q1 | 700 355.25 € | 63 557.78 € | 67 967.69 € | 38 |
2020 Q4 | 1 037 995.2 € | 102 166.6 € | 105 646.58 € | 37 |
2020 Q3 | 764 928.49 € | 82 037.7 € | 86 326.61 € | 36 |
2020 Q2 | 771 366.31 € | 98 099.48 € | 100 293.45 € | 38 |
2020 Q1 | 497 062.7 € | 85 082.83 € | 90 767.91 € | 37 |